{"TopicDetails": {"type": 0, "ccm2Id": 46650133, "cftId": 0, "identifier": "HORIZON-JU-IHI-2024-07-03-singe-stage", "title": "Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response", "publicationDateLong": 1705363200000, "callIdentifier": "HORIZON-JU-IHI-2024-07-single-stage", "callTitle": "Innovative Health Initiative JU Call 7", "callccm2Id": 46650138, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 45177852, "abbreviation": "HORIZON.2.1.7", "description": "Innovative Health Initiative"}, {"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "keywords": ["Healthcare system", "Diagnostic technology", "Personalised care solutions", "Personalised treatment", "Drug development, clinical phases", "Biomarkers", "Clinical trials"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "16 January 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["22 May 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3531600": [{"action": "HORIZON-JU-IHI-2024-07-03-singe-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "16 January 2024", "deadlineModel": "single-stage", "deadlineDates": ["22 May 2024"], "budgetYearMap": {"2023": 95000000}, "expectedGrants": 3, "minContribution": 10000000, "maxContribution": 15000000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-07-01-singe-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "16 January 2024", "deadlineModel": "single-stage", "deadlineDates": ["22 May 2024"], "budgetYearMap": {"2023": 95000000}, "expectedGrants": 2, "minContribution": 10000000, "maxContribution": 12500000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-07-02-singe-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "16 January 2024", "deadlineModel": "single-stage", "deadlineDates": ["22 May 2024"], "budgetYearMap": {"2023": 95000000}, "expectedGrants": 2, "minContribution": 10000000, "maxContribution": 12500000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2023"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>Actions under this topic must contribute to all the following expected outcomes:</p><ul level=\"0\"><li>Access for healthcare professionals to novel, robust and fit for purpose biomarkers<sup>1</sup> with linked technologies enabling their use in clinical setting and progress towards validation. Biomarkers and linked technologies may be for diagnosis, monitoring disease progression, selecting the optimal therapeutic treatments, or assessing treatment response.</li><li>Availability for researchers of robust and fit-for-purpose biomarkers with linked technologies enabling their clinical use for diagnosing disease, disease monitoring, or monitoring treatment response. This will enable researchers to develop safer and more effective personalised treatments tailored to the individual\u2019s characteristics and the stage of their disease. Alternatively, availability for researchers of key technology (e.g. companion diagnostics) that could be essential for the safe and appropriate use and selection of a corresponding drug or biological product or its development.</li><li>Availability for regulators of robust evidence on the suitability of selected biomarkers and their linked technologies to enable regulatory acceptance for a specific use.</li> </ul><p><sup>1</sup> <sub>See definition as in the <a href=\"http://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/IHI_SRIA_ApprovedJan22.pdf\">IHI JU Strategic Research and Innovation Agenda </a>(Glossary): BIOMARKERS are biological characteristics, which can be molecular, anatomic, physiologic, or biochemical. These characteristics can be measured and evaluated objectively. They act as indicators of a normal or a pathogenic biological process. They allow the assessment of the pharmacological response to a therapeutic intervention. A biomarker shows a specific physical trait or a measurable biologically-produced change in the body that is linked to a disease or a particular health condition. A biomarker may be used to assess or detect a specific disease as early as possible (diagnostic biomarker), the risk of developing a disease (susceptibility/risk biomarker), the evolution of a disease (prognostic biomarker) \u2013 but it can also predict response to a given treatment including potential toxicity (predictive biomarker). </sub></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Biomarker-driven approaches for diagnosis, monitoring disease progression and assessing treatment response have immense potential to help us progress precision medicine. Despite intense research, few biomarkers are subject to rigorous testing in clinical settings and shown to be fit for purpose (clinically validated). In addition, while there are several novel biomarkers that have shown significant promise for a number of use cases, often the technology to make them accessible for clinical use is not mature enough, which hampers their validation for use. Thus, technology development or improvements to existing technologies may be required to progress these biomarkers to clinical validation. For example, there are many novel and highly innovative technologies in development (e.g. imaging, artificial intelligence (AI), omics markers, phage-based diagnostics in multiple formats among others) and their further development and validation would be a necessary element for validating their detected biomarkers in the clinic.</p><p>Furthermore, different healthcare actors (e.g. academics, clinicians, patients, health technology developers and regulators) may have different definitions and expectations on the utilities of biomarkers, and there is a need for an aligned methodological framework for scaling up the clinical validation of candidate biomarkers.</p><p>To address this challenge, this topic aims:</p><ul level=\"0\"><li>to progress candidate biomarkers towards clinical validation and, when relevant, to regulatory acceptance;</li> </ul><p>and/or</p><ul level=\"0\"><li>to progress towards clinical validation innovative technologies necessary for making biomarker(s) accessible for clinical use. In proposals focusing uniquely on these technologies, applicants should justify how such progress will enable the validation of the biomarker(s) for use in a clinical context.</li> </ul><p>Projects funded under this topic should:</p><ul level=\"0\"><li>Assemble a cross-sectoral public-private partnership to align and develop a methodological framework and roadmap for progressing selected candidate biomarker(s) and/or linked technologies enabling the clinical use of the biomarker(s) (or a combination thereof) to rigorous clinical validation</li><li>Provide a justification and clearly demonstrate why the proposal area responds to an unmet public health need<sup>1</sup>.</li><li>Progress biomarker(s) and/or technologies towards clinical and analytical validation in one or more of these areas: diagnosing disease, early treatment path selection, monitoring disease progression, or treatment response assessment:   <ul level=\"1\"><li>All types of biomarkers including digital, combinations of biomarkers and multimodal biomarkers are in scope. Proposals addressing biomarker(s) intended for specific populations such as the elderly or children are very welcome.</li><li>The candidate biomarkers can be combined with existing biomarkers for more personalised decision making.</li><li>All types of technologies for progressing biomarkers to a stage closer to clinical validation, including innovative and novel approaches, are in scope. Some examples could be technologies for the effective collection, preparation, measurement and analysis of samples and biomarkers, or diagnostic equipment, methods, or systems.</li><li>In their proposal, applicants must clearly identify the candidate biomarker(s) and/or linked technology(ies) and the proposed application in research and development (R&amp;D) and/or clinical practice.</li><li>Applicants should provide in their proposal sufficient preliminary evidence, including relevant methodology(ies) and high-quality data to demonstrate that the biomarker(s) and/or technology(ies) can be progressed towards clinical validation and, when relevant, to regulatory acceptance.</li><li>As relevant, applicants must ensure effective collection, preparation, measurement, and analysis of biomarker samples to allow validation in the clinical setting.</li>   </ul> </li><li>Build on existing solutions to develop a collaborative platform to integrate, analyse and share data (historical or generated de novo) gathered for the validation of biomarker(s) and/or linked technologies during the project, as well as to support future biomarker validation beyond the project duration. Applicants should plan to ensure the future scalability and sustainability of the platform and future data sharing and ensure adherence to FAIR (findable, accessible, interoperable, reusable) principles.</li><li>Develop a regulatory strategy and interaction plan for evidence generation to support the regulatory qualification of the biomarker/s and/or technologies and engage with regulators in a timely manner (e.g. national competent authorities, European Medicines Agency (EMA) Innovation Task Force, qualification advice). Applicants should reserve resources to support these interactions.</li><li>Elaborate a plan for interacting with all the relevant actors in the learning healthcare system (for example clinicians, academic researchers, healthcare professionals, health technology developers, regulators, policy makers, and others as relevant) to align on utilities of the candidate biomarker(s) and/or technologies for clinical use and guide the roadmap.</li><li>Disseminate the results of the project to ensure uptake by relevant stakeholders, including healthcare systems and technology developers.</li><li>Applicants should also reserve resources to synergise with other relevant initiatives, including other projects funded under this topic and those funded under IHI Call 3 topic 1<sup>2 </sup>as relevant.</li> </ul><p><sup>1 </sup><sub>See definition in Art 125.1 of the <a href=\"http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32021R2085\">Council Regulation (EU) 2021/2085</a> establishing the Joint Undertakings under Horizon Europe: \u201cAn unmet public health need shall be defined as a need currently not addressed by the health care systems for availability or accessibility reasons, for example where there is no satisfactory method of diagnosis, prevention or treatment for a given health condition or if people\u2019s access to health care is limited because of cost, distance to health facilities or waiting times.\u201d</sub></p><p><sup>2</sup><sub> <sup><a href=\"https://www.ihi.europa.eu/apply-funding/ihi-call-3\">https://www.ihi.europa.eu/apply-funding/ihi-call-3</a> </sup></sub></p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>Actions under this topic are expected to achieve the following impacts:</p><ul level=\"0\"><li>New clinically-validated biomarker-driven approaches are available that lead, as relevant, to more precise and effective diagnosis, leaner diagnosis-to-treatment pathways, better treatment path selection, or improved follow-up and treatment response assessment and monitoring.</li><li>A significant reduction in the diagnostic or therapeutic burden for patients (and caregivers) for example by favouring non- or minimally-invasive approaches.</li><li>Validated tools and approaches supporting evidence-based health and care decisions addressing both the needs of patients and of healthcare systems.</li><li>An increase in the competitiveness of European health industries.</li> </ul>\n", "conditions": "<h1><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">General conditions</span></b></span></span></span></h1>\r\n<p class=\"MsoNormal\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\">described in </span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex A</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">and </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex E</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Horizon Europe Work Programme General Annexes</span></span></span></p>\n<p style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\"> described in Part B of the Application Form available in the Submission System</span></span></span></span></p>\r\n<p style=\"margin-left: 40px;\">&nbsp;<!--[if !supportLists]--><span style=\"font-size:10.0pt;&#10;mso-bidi-font-size:8.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings;&#10;mso-bidi-font-family:Wingdings;color:#333333\"><span style=\"mso-list:Ignore\">&sect;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp; </span></span></span><!--[endif]--><span lang=\"EN-US\" style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;&#10;mso-ansi-language:EN-US\">for a single-stage Call, the limit for RIA full proposals is 50 pages</span><span style=\"font-size:8.0pt;font-family:&quot;Helvetica&quot;,sans-serif;&#10;color:#333333\"><o:p></o:p></span></p>\r\n<p>&nbsp;</p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">2. Eligible countries: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;&#10;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Horizon Europe Programme Guide</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">.</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\"> described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> <span lang=\"EN-US\">of the Work Programme General Annexes&nbsp;</span></span></span></span><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 107%; font-family: Arial, sans-serif;\">and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the&nbsp;</span><span style=\"font-size: 10pt; line-height: 107%; font-family: Calibri, sans-serif;\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\" target=\"_blank\"><span lang=\"EN-US\" style=\"font-family:&quot;Arial&quot;,sans-serif;&#10;color:#2897B7;mso-ansi-language:EN-US\">IHI JU Work Programme (WP)</span></a></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b>4. Financial and operational capacity and exclusion: </b>described in </span></span></span><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex C</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> of the Work Programme General Annexes</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></span></span></span></p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Award criteria, scoring and      thresholds</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      D</span></span></a></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">of      the Work Programme General Annexes&nbsp;</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span>and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the&nbsp;<span style=\"font-size: 10pt; line-height: 107%; font-family: Arial, sans-serif;\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\"><span lang=\"EN-US\">IHI JU Work Programme (WP)</span></a></span></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span></span></span></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Online      Manual</span></span></a><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex G</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span></p>\r\n<p>&nbsp;</p>\n<h1><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">Specific conditions</span></b></span></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\" style=\"mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;&#10;line-height:normal\"><b><span lang=\"EN-US\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">7. Specific conditions: </span></b><span lang=\"EN-US\" style=\"font-size: 10pt; font-family: Arial, sans-serif;\">described in the&nbsp;''Conditions of the Calls for proposals and Calls management rules'' section of the&nbsp;</span><span style=\"font-size: 10pt; font-family: Arial, sans-serif;\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\" target=\"_blank\"><span lang=\"EN-US\" style=\"color:blue;mso-ansi-language:EN-US\">IHI JU Work Programme (WP)</span></a><o:p></o:p></span></p>\r\n<ul>\r\n    <li>&nbsp;<span style=\"font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:&#10;     &quot;Times New Roman&quot;;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">specific      conditions on Availability, Accessibility and Affordability (3A) <strong>apply to this topic</strong><o:p></o:p></span></li>\r\n    <li class=\"MsoNormal\" style=\"line-height: normal;\"><span style=\"font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-fareast-font-family:&#10;     &quot;Times New Roman&quot;;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB\">JU's      right to object to transfer/exclusive licensing<o:p></o:p></span></li>\r\n</ul>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\"><o:p></o:p></span></p>\n<h1><span style=\"font-size: medium;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\"><span style=\"font-family: Arial;\">Documents</span></span></b></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Where relevant, templates of the reference documents and associated guidance can be found on the&nbsp;IHI JU&nbsp;</span></b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\"><b>website</b></a><b>&nbsp;.</b><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\">&nbsp;<b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Regarding the application forms for submitting proposals, the relevant templates and annexes are available to download in the submission system.</span></b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\">&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\">&nbsp;<span lang=\"EN-US\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The IHI JU 7</span><sup><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">th</span></sup><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;</span><span lang=\"EN-US\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Call for proposals full topics text is available&nbsp;</span><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Call7_CallText.pdf\" target=\"_blank\"><span lang=\"EN-US\">here</span></a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Evaluation form (single and two-stage Calls)</span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Evaluation_form_RIA_UpdateDec2023.pdf\">IHI JU Evaluation form for Research and Innovation Actions&nbsp;</a>(single and two-stage Calls)<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;</span><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Proposal Templates Part A and Part B (Research and Innovation Actions &ndash; single-stage and second stage of two-stage procedure)&nbsp;</span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;&nbsp;</span><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Proposal template - Part A</span></b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"> of the proposal is generated by the IT system in the submission environment (for more information see the HE Part A template&nbsp;</span><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia_en.pdf\"><span lang=\"EN-IE\">here</span></a></span><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">). In Part A of the proposal applicants insert general information on their proposal (e.g. proposal acronym), details on the participants, on the budget, information on Ethics and Security, as well as other type of questions (e.g. information on clinical studies). Please note that&nbsp;only&nbsp;Part A of this template is applicable for this call. For Part B, see point below.</span><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Proposal_template_RIA_FP_PartB_UpdateDec2023.pdf\"><span lang=\"EN-IE\">IHI JU Proposal template (RIA/FP) - Part B</span></a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Proposal Annexes</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;<b>Annex: Type of Participants</b><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The &ldquo;<i>type of participants&rdquo;</i>&nbsp;is an IHI specific annex. The excel template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants.xlsx\">here</a>&nbsp;and the instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants_instrucctions.pdf\">here</a>.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is a compulsory annex and it must be uploaded as a separate document in the submission system.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This annex is applicable to single-stage and both stages of two-stage Calls.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Annex: Declaration of in-kind contribution commitment</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The &ldquo;<i>Declaration of in-kind contribution commitment&rdquo;</i>&nbsp;is an IHI specific annex.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The word document template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_commitment%20.pdf\">here</a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This annex&nbsp;</span></i><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;is applicable to all single-stages calls and the second stage of two-stage calls</span></i><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;</span></b><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Annex: In-kind contributions to additional activities (IKAA)</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The &lsquo;<i>&rsquo;In-kind contributions to additional activities (IKAA)&rsquo;&rsquo;</i>&nbsp;is an IHI specific annex. The excel template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_declaration_in_kind_contribution_additional_activities_UpdateDec2023.xlsx\">here</a>&nbsp;and the instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_additional_activities_instructions.pdf\">here</a>.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is an optional annex and it is applicable to all single-stages calls and the second stage of two-stage calls.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;</span></b><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Annex: Essential information for clinical studies</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The information on clinical studies is a Horizon Europe annex.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><u><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">If your proposal does not include clinical studies, please upload a statement declaring your proposal does not include clinical studies.<o:p></o:p></span></u></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The information on clinical studies annex can be found&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx\">here</a>:<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">The annex is applicable only</span></i><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;to all single-stages calls and the second stage of two-stage calls</span></i><i><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Annex: Ethics</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is a HE annex. Ethics self-assessment should be included in proposal part A. However, in Calls where several serious ethics issues are expected, the characters limit in this section of proposal part A may not be sufficient for participants to give all necessary information. In those cases, participants may include additional information in an annex to proposal part B.&nbsp;<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is an optional annex and it is applicable to all single-stage calls and the second stage of two-stage calls.</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">- Annex to the budget for the Full Proposal&nbsp;</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This is a compulsory&nbsp;</span></i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Annex_Budget_for_full_Proposal_SINGLE_stage_call_UpdateDec2023.xlsx\"><i>annex</i></a>, which complements the budget figures already included in the proposal budget in PART A. Its purpose is to correctly guide the consortium in providing IHI-specific budget items (e.g. IKOP, IKAA, FC PAID, FC RECEIVED, etc.) and to comply with IHI additional eligibility criteria (e.g. 45% industry contribution).<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">This annex&nbsp;</span></i><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;is applicable to all single-stages calls and the second stage of two-stage calls</span></i><i><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">.</span></i></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"> </span><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Model Grant Agreement (MGA)</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE&nbsp;General MGA v1.0</a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><o:p>&nbsp;</o:p></p>\r\n<p style=\"margin:0cm\"><span style=\"font-size:8.0pt;font-family:&quot;Helvetica&quot;,sans-serif;color:black\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p>&nbsp;</p>\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Additional documents:</span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><br />\r\n-&nbsp;<a href=\"https://eur-lex.europa.eu/eli/reg/2021/2085\">Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014</a>&nbsp;&nbsp;(in short Single Basic Act &lsquo;SBA&rsquo; or Council Regulation (EU) 2021/2085).<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\" target=\"_blank\"><span lang=\"EN-US\">IHI JU Work Programme (WP)</span></a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/flmngr/IHI_Strategic_Research_and_Innovation_Agenda_3.pdf\">Strategic Research and Innovation Agenda (SRIA)</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Guide_for_Applicants.pdf\" target=\"_blank\">IHI JU Guide for Applicants</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Call_FAQs.pdf\" target=\"_blank\">IHI&nbsp;JU&nbsp;FAQs</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">Horizon Europe Reference Documents<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-1-general-introduction_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 1. General Introduction</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-4-health_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 4. Health</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-12-missions_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 12. Missions</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 13. General Annexes</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\">HE Programme Guide</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\">HE Framework Programme and Rules for Participation Regulation 2021/695</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\">HE Specific Programme Decision 2021/764</a></span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span lang=\"EN-US\">EU Financial Regulation</span></a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\"><span lang=\"EN-US\">EU Grants AGA&nbsp;</span>&mdash; Annotated Model Grant Agreement</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\">Funding &amp; Tenders Portal Terms and Conditions</a><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;</span></b><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\">Funding &amp; Tenders Portal Privacy Statement</a></span></b><b><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;</span></b></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-IE\">&nbsp;</span></p>", "supportInfo": "<p style=\"box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-variant-alternates: inherit; font-variant-position: inherit; font-stretch: inherit; line-height: inherit; font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; font-size: 14px; margin: 0px 0px 1rem; padding: 0px; color: rgb(51, 51, 51);\">&nbsp;<span style=\"font-family: inherit; font-size: var(--eui-font-size); font-style: inherit; font-variant: inherit; font-weight: inherit; box-sizing: border-box; border: 0px; font-stretch: inherit; line-height: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">All the information concerning the IHI JU Calls is also published on the&nbsp;</span><a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\" target=\"_blank\" style=\"font-family: inherit; font-size: var(--eui-font-size); font-style: inherit; font-variant: inherit; font-weight: inherit; background-color: initial; box-sizing: border-box; border: 0px; font-stretch: inherit; line-height: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px; touch-action: manipulation; cursor: pointer; text-decoration-line: none;\">IHI JU website</a><span style=\"font-family: inherit; font-size: var(--eui-font-size); font-style: inherit; font-variant: inherit; font-weight: inherit; box-sizing: border-box; border: 0px; font-stretch: inherit; line-height: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">.&nbsp;</span><span style=\"font-family: inherit; font-size: var(--eui-font-size); font-style: inherit; font-variant: inherit; font-weight: inherit; box-sizing: border-box; border: 0px; font-stretch: inherit; line-height: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">&nbsp;&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; font-size: var(--eui-font-size); margin-top: var(--eui-spacing); margin-right: 0px; margin-bottom: 1rem; margin-left: 0px; padding: 0px;\"><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">All the questions pertaining to the IHI JU Calls are to be addressed to&nbsp;</span><a href=\"mailto:infodesk@ihi.europa.eu\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px; touch-action: manipulation; cursor: pointer; background-color: initial; text-decoration-line: none;\">infodesk@ihi.europa.eu</a><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">.</span></p>\r\n<p>&nbsp;</p>\r\n<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><b><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" target=\"_blank\">Online Manual</a>&nbsp;</b></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Aug 1, 2024 4:37:58 PM", "lastChangeDate": "Aug 1, 2024 4:37:58 PM", "content": "<div>An overview of the evaluation results of the IHI Call 7 can be found in the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/C7_FlashInfo.pdf\" target=\"_blank\">Flash Call Info Report</a>.</div>"}, {"approvalDate": "May 23, 2024 8:56:54 AM", "lastChangeDate": "May 23, 2024 8:56:54 AM", "content": "<div>Call HORIZON-JU-IHI-2024-07-single-stage has closed as of 22nd May 2024.</div>\r\n<div>&nbsp;</div>\r\n<div>28 proposals have been submitted in total. The breakdown per topic is:</div>\r\n<ul>\r\n    <li>HORIZON-JU-IHI-2024-07-01: 9 proposals</li>\r\n    <li>HORIZON-JU-IHI-2024-07-02: 8 proposals</li>\r\n    <li>HORIZON-JU-IHI-2024-07-03: 11 proposals</li>\r\n</ul>\r\n<div>Evaluation results are expected to be communicated in July 2024.</div>"}, {"approvalDate": "Jan 16, 2024 12:00:03 AM", "lastChangeDate": "Jan 16, 2024 12:00:03 AM", "content": "The submission session is now available for: HORIZON-JU-IHI-2024-07-02-singe-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-07-03-singe-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-07-01-singe-stage(HORIZON-JU-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}